CANCann Group
About Cann Group
Cann Group (ASX:CAN) is an Australian medical cannabis company with operations in Australia, Europe, and North America. The company's core business is the cultivation, manufacture, and distribution of medical cannabis products. Cann Group also has a number of research and development projects underway, including the development of new medical cannabis products and the use of cannabis for the treatment of specific medical conditions. Cann Group aims to develop new medical cannabis products: Cann Group is committed to the development of new medical cannabis products.
What is CAN known for?
Snapshot
Public AU
Ownership
2014
Year founded
96
Employees
Victoria, Australia
Head office
1 of 382
AU Rank
Unknown
Sector
N/A
Sector rank
Loading Map...
Operations
All Locations
Australia
Products and/or services of Cann Group
- Mildura Facility: Cann Group's flagship cultivation and manufacturing facility. It is the largest medical cannabis facility in the Southern Hemisphere and has a production capacity of over 100 tonnes of dried cannabis flower per year.
- R&D Bundoora Facility at La Trobe University, Bundoora: Focuses on genetics, growing techniques, and tissue culture. It includes certified greenhouse cultivation and laboratory facilities at physical containment level-2.
Cann Group executive team
- Ms. Jennifer Lee Pilcher AGIA, BBS, C.A.CEO, MD & Executive Director
- Mr. Steven Notaro BA, J.D.Head of Legal and Regulatory Affairs & Company Secretary